Anthrax as a Bioweapon

On this page

Introduction - The Silent Spore

  • Causative Agent: Bacillus anthracis.
    • Features: Gram-positive, aerobic, spore-forming rod.
    • Spores: Highly resilient, enable environmental persistence and transmission.
  • Primary Virulence: Tripartite exotoxin.
    • Protective Antigen (PA): Binds host cells, mediates entry of EF & LF.
    • Edema Factor (EF): Adenylate cyclase; causes edema by disrupting water homeostasis.
    • Lethal Factor (LF): Zinc metalloprotease; cleaves MAPKKs, causes cell death.
  • 📌 Mnemonic (Toxin Components): Protective Antigen Lets Edema Factor In (PA-LF-EF).

⭐ Spores can survive for decades in soil, posing a long-term threat. Bacillus anthracis Gram stain with endospores Anthrax toxin mechanism of actionoka

Bioweaponization - Spores of War

Life cycle of B. anthracis

  • Spore Stability: Bacillus anthracis spores are highly resilient; can survive harsh conditions for decades in soil/environment.
  • Aerosol Dispersal: Fine spore powder is ideal for aerosolization, leading to widespread, silent dissemination.
  • High Mortality (Inhalational): Inhalational anthrax has a case fatality rate approaching 100% if untreated. LD50: ~2,500-55,000 spores.
  • Public Panic & Disruption: Outbreaks induce significant societal fear, overwhelming public health systems.

⭐ Inhalational anthrax is the most lethal form and the primary concern in bioterrorism.

Clinical Picture - Deadly Dust

Anthrax manifests via three routes, each with distinct clinical features:

FeatureInhalational AnthraxCutaneous AnthraxGastrointestinal Anthrax
Incubation1-60 days1-12 days1-7 days
PresentationBiphasic: Flu-like prodrome → fulminant dyspnea, hemorrhagic mediastinitis, shockPainless papule → vesicle → necrotic ulcer with characteristic black escharRare; severe GI distress (nausea, bloody diarrhea)
MortalityVery HighLow (if treated)High

⭐ Widened mediastinum on chest X-ray is a hallmark of inhalational anthrax.

Dx & Rx - Race Against Toxin

  • Diagnosis
    • Imaging: CXR/CT (widened mediastinum).
    • Microbiology: Blood culture.
    • Molecular: PCR (blood, pleural fluid, CSF).
    • Epidemiology: Nasal swabs (contact tracing, not individual Dx).
  • Treatment (Inhalational/Systemic Anthrax)
    • Core: IV Ciprofloxacin OR Doxycycline.
    • PLUS: A protein synthesis inhibitor (e.g., Clindamycin, Linezolid).
    • AND/OR: A cell wall active agent (e.g., Meropenem, esp. severe/meningitis).
    • Antitoxins: Raxibacumab, Obiltoxaximab (neutralize toxins).
  • Post-Exposure Prophylaxis (PEP)
    • Antibiotics: Oral Ciprofloxacin or Doxycycline for 60 days.
    • Vaccine: PLUS 3 doses of anthrax vaccine if available.

⭐ Early antibiotic treatment is crucial for survival in inhalational anthrax; mortality approaches 100% if treatment is delayed.

Prevention & Control - Breaking the Chain

  • Vaccination:
    • Anthrax Vaccine Adsorbed (AVA): Pre-exposure prophylaxis (PrEP) for high-risk groups (e.g., military, lab personnel).
  • Decontamination:
    • Sporicidal agents (e.g., chlorine dioxide, formaldehyde) for environmental surfaces, equipment.
  • Public Health Measures:
    • Surveillance, prompt reporting, contact tracing.
    • Isolation for cutaneous anthrax with draining lesions (standard precautions).

⭐ Anthrax vaccine (AVA) is typically administered as a multi-dose series for pre-exposure prophylaxis in at-risk personnel.

High‑Yield Points - ⚡ Biggest Takeaways

  • Bacillus anthracis: A Gram-positive, spore-forming rod, key bioterrorism agent.
  • Inhalational anthrax: Most lethal; causes hemorrhagic mediastinitis & widened mediastinum (CXR).
  • Cutaneous anthrax: Characterized by a painless black eschar.
  • Anthrax spores: Highly resilient, easily aerosolized for weaponization.
  • Virulence factors: Poly-D-glutamic acid capsule and tripartite toxin (PA, LF, EF).
  • Treatment: Ciprofloxacin or Doxycycline are first-line; antitoxin often used.
  • Post-exposure prophylaxis (PEP): Crucial with antibiotics for 60 days post-exposure.

Practice Questions: Anthrax as a Bioweapon

Test your understanding with these related questions

Post-exposure prophylaxis is indicated in?

1 of 5

Flashcards: Anthrax as a Bioweapon

1/3

_____ makes three exotoxic proteins; protective antigen (PA), lethal factor (LF), and edema factor (EF)

TAP TO REVEAL ANSWER

_____ makes three exotoxic proteins; protective antigen (PA), lethal factor (LF), and edema factor (EF)

Bacillus Anthracis

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial